Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-3-3
pubmed:abstractText
To assess the pharmacogenomic and pharmacokinetic determinants of skin rash and diarrhea, the two primary dose-limiting toxicities of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ABCG2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ATP-Binding Cassette Transporters, http://linkedlifedata.com/resource/pubmed/chemical/CYP3A4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CYP3A5 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/erlotinib
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1119-27
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18309947-ATP-Binding Cassette Transporters, pubmed-meshheading:18309947-Adult, pubmed-meshheading:18309947-Aged, pubmed-meshheading:18309947-Aged, 80 and over, pubmed-meshheading:18309947-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:18309947-Cytochrome P-450 CYP3A, pubmed-meshheading:18309947-Cytochrome P-450 Enzyme System, pubmed-meshheading:18309947-Diarrhea, pubmed-meshheading:18309947-Exanthema, pubmed-meshheading:18309947-Female, pubmed-meshheading:18309947-Head and Neck Neoplasms, pubmed-meshheading:18309947-Humans, pubmed-meshheading:18309947-Lung Neoplasms, pubmed-meshheading:18309947-Male, pubmed-meshheading:18309947-Middle Aged, pubmed-meshheading:18309947-Neoplasm Proteins, pubmed-meshheading:18309947-Neoplasms, Squamous Cell, pubmed-meshheading:18309947-Ovarian Neoplasms, pubmed-meshheading:18309947-Pharmacogenetics, pubmed-meshheading:18309947-Polymorphism, Genetic, pubmed-meshheading:18309947-Prospective Studies, pubmed-meshheading:18309947-Protein Kinase Inhibitors, pubmed-meshheading:18309947-Quinazolines, pubmed-meshheading:18309947-Receptor, Epidermal Growth Factor
pubmed:year
2008
pubmed:articleTitle
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
pubmed:affiliation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, David H. Koch Cancer Research Building, Room 544, 1550 Orleans St, Baltimore, MD 21231, USA. rudin@jhmi.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural